Literature DB >> 1641039

Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy.

M Sendtner1, H Schmalbruch, K A Stöckli, P Carroll, G W Kreutzberg, H Thoenen.   

Abstract

Ciliary neurotrophic factor (CNTF) supports the survival of embryonic motor neurons in vitro and in vivo, and prevents lesion-mediated degeneration of rat motor neurons during early post-natal stages. Here we report that CNTF greatly reduces all the functional and morphological changes in pmn/pmn mice, an autosomal recessive mutant leading to progressive caudo-cranial motor neuron degeneration. The first manifestations of progressive motor neuronopathy in homozygous pmn/pmn mice become apparent in the hind limbs at the end of the third post-natal week, and all the mice die up to 6 or 7 weeks after birth from respiratory paralysis. Treatment with CNTF prolongs survival and greatly improves motor function of these mice. Moreover, morphological manifestations, such as loss of motor axons in the phrenic nerve and degeneration of facial motor neurons, were greatly reduced by CNTF, although the treatment did not start until the first symptoms of the disease had already become apparent and substantial degenerative changes were already present. The protective and restorative effects of CNTF in this mouse mutant give new perspectives for the treatment of human degenerative motor neuron diseases with CNTF.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1641039     DOI: 10.1038/358502a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  103 in total

Review 1.  Progress in the pathogenesis of amyotrophic lateral sclerosis.

Authors:  C E Shaw; A al-Chalabi; N Leigh
Journal:  Curr Neurol Neurosci Rep       Date:  2001-01       Impact factor: 5.081

2.  Endogenous ciliary neurotrophic factor is a lesion factor for axotomized motoneurons in adult mice.

Authors:  M Sendtner; R Götz; B Holtmann; H Thoenen
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

Review 3.  Treatment of amyotrophic lateral sclerosis.

Authors:  A Eisen; M Weber
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

4.  Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease.

Authors:  K D Anderson; N Panayotatos; T L Corcoran; R M Lindsay; S J Wiegand
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 5.  Anterograde transport of neurotrophic factors: possible therapeutic implications.

Authors:  Matteo Caleo; Maria Cristina Cenni
Journal:  Mol Neurobiol       Date:  2004-04       Impact factor: 5.590

6.  Engineering a potent receptor superagonist or antagonist from a novel IL-6 family cytokine ligand.

Authors:  Jun W Kim; Cesar P Marquez; R Andres Parra Sperberg; Jiaxiang Wu; Won G Bae; Po-Ssu Huang; E Alejandro Sweet-Cordero; Jennifer R Cochran
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-10       Impact factor: 11.205

7.  Ciliary neurotrophic factor improves muscle fibre reinnervation after facial nerve crush in young rats.

Authors:  H J Ulenkate; E C Kaal; W H Gispen; F G Jennekens
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  Adult ciliary neurotrophic factor receptors help maintain facial motor neuron choline acetyltransferase expression in vivo following nerve crush.

Authors:  Nancy Lee; Carolyn E Rydyznski; Matthew S Rasch; Dennis S Trinh; A John MacLennan
Journal:  J Comp Neurol       Date:  2016-11-07       Impact factor: 3.215

9.  Structure-function studies of human ciliary neurotrophic factor.

Authors:  A Negro; V Corsa; G Corona; C Grandi; S D Skaper; L Callegaro
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

10.  A role for ciliary neurotrophic factor as an inducer of reactive gliosis, the glial response to central nervous system injury.

Authors:  C G Winter; Y Saotome; S W Levison; D Hirsh
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.